Pharmaceutical companies stalling on new plans

Reflecting increasing market uncertainty in the domestic market, pharmaceutical drug makers are still delaying the formulation of their business plans for this year.

Companies usually flesh out their sales targets, profit goals, investment scale and other key components of their plans finalized around November.

But now, they say that things are put on hold, not knowing what to expect thi...